Tevogen holders reelect two directors, back KPMG and charter changes at annual meeting

Tevogen Inc. held its annual stockholders meeting on August 24, 2026, according to a Form 8-K filed with the SEC. On August 24, 2026, Tevogen Inc. held an annual meeting of its stockholders.¹

As of the July 23, 2026 record date, there were 6,416,540 shares of the Company's Common Stock issued and outstanding and entitled to vote, and holders of 5,956,141 shares were represented in person or by proxy, constituting a quorum.¹

Stockholders reelected Dr. Keow Lin Goh and Victor Sordillo as Class II directors. Dr. Goh received 5,397,703 votes for, 22,265 against, 2,653 abstentions and 533,520 broker non-votes; Sordillo received 5,395,249 votes for, 24,751 against, 2,621 abstentions and 533,520 broker non-votes.¹

Shareholders also voted on KPMG's role as auditor. The company's stockholders ratified the appointment of KPMG LLP to serve as its independent registered public accounting firm for the fiscal year ending December 31, 2026.¹

Investors approved an increase to the equity incentive pool. The plan amendment raises the number of shares of common stock available for issuance under the Tevogen Inc. 2024 Omnibus Incentive Plan by 100,000,000 shares.¹

A charter change was also approved and implemented. On August 26, 2026, following the board's recommendation and stockholder approval at the annual meeting, the company filed a Certificate of Amendment to its Certificate of Incorporation with the Delaware Secretary of State, allowing stockholders to act by written consent in lieu of a meeting, effective immediately upon filing.¹